A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Alglucosidase alfa
Grazoprevir
The excretion of Grazoprevir can be decreased when combined with Cholecystokinin.
Alglucosidase alfa
Selexipag
The excretion of Selexipag can be decreased when combined with Cholecystokinin.
Alglucosidase alfa
Tenofovir alafenamide
The excretion of Tenofovir alafenamide can be decreased when combined with Cholecystokinin.
Alglucosidase alfa
Paritaprevir
The excretion of Paritaprevir can be decreased when combined with Cholecystokinin.
Alglucosidase alfa
Fimasartan
The excretion of Fimasartan can be decreased when combined with Cholecystokinin.
Alglucosidase alfa
Technetium Tc-99m mebrofenin
The excretion of Technetium Tc-99m mebrofenin can be decreased when combined with Cholecystokinin.
Alglucosidase alfa
Gadoxetic acid
The excretion of Gadoxetic acid can be decreased when combined with Cholecystokinin.
Alglucosidase alfa
Atrasentan
The excretion of Atrasentan can be decreased when combined with Cholecystokinin.
Alglucosidase alfa
Apalutamide
The excretion of Cholecystokinin can be increased when combined with Apalutamide.
Alglucosidase alfa
Eluxadoline
The serum concentration of Eluxadoline can be increased when it is combined with Cholecystokinin.
Idursulfase
Oliceridine
The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when DPDPE is combined with Oliceridine.
Idursulfase
Remimazolam
The risk or severity of sedation can be increased when DPDPE is combined with Remimazolam.
Idursulfase
Ziconotide
The risk or severity of adverse effects can be increased when Ziconotide is combined with DPDPE.
Idursulfase
Lasmiditan
The risk or severity of serotonin syndrome can be increased when DPDPE is combined with Lasmiditan.
Idursulfase
Naphazoline
Naphazoline may increase the central nervous system depressant (CNS depressant) activities of DPDPE.
Idursulfase
Potassium cation
The therapeutic efficacy of Potassium cation can be decreased when used in combination with DPDPE.
Idursulfase
Potassium
The therapeutic efficacy of Potassium can be decreased when used in combination with DPDPE.
Idursulfase
Bromotheophylline
The therapeutic efficacy of Bromotheophylline can be decreased when used in combination with DPDPE.
Idursulfase
Epitizide
The therapeutic efficacy of Epitizide can be decreased when used in combination with DPDPE.
Idursulfase
Xipamide
The therapeutic efficacy of Xipamide can be decreased when used in combination with DPDPE.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3